-

Susan G. Komen® Announces CEO Paula Schneider to Step Down

Schneider to Assume New Role as Honorary Vice Chair

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today announced that President and Chief Executive Officer Paula Schneider has shared that she will step down from the CEO role after seven years of transformational leadership. Schneider will continue to serve the organization as Honorary Vice Chair, using her renowned and respected voice to support the urgent mission to end deaths from breast cancer in our lifetime.

During her tenure, Schneider led Komen through a critical period, transforming Komen’s national network of local affiliate organizations into a single, unified entity to increase efficiency and impact across the country. Under her leadership, Komen accelerated research, advocacy, community outreach, and patient care, leaving the organization well-positioned for future success. To date, Komen has invested more than $3.5 billion in these critical areas, advancing its mission to save lives and to prevent and cure breast cancer.

“I’m enormously proud of the meaningful work our team has done and the progress we’ve made in our shared mission to save lives,” said Paula Schneider. “Our mission has never been more urgent. In my new role at Komen, I will focus on continuing to broadcast our message to extend our reach and heighten our impact.”

“The Board of Directors is deeply grateful to Paula for her exceptional service and unwavering commitment to Komen’s mission,” said the Chair of the Board of Directors, Ed Dandridge. “Her leadership has been instrumental in transforming this organization. Komen is well-positioned to enter its next chapter, and we look forward to identifying the leader who will follow in her footsteps to guide Komen’s continued transformation.”

During the leadership transition, a committee comprised of Komen board members and Komen senior leaders will guide Komen’s executive responsibilities while the Board conducts a national search for a successor. This collaborative interim leadership model ensures continuity, stability, and continued momentum across the organization’s mission priorities.

The leadership succession comes at a time of strength for Susan G. Komen – which has a clear mission, a pivotal role in supporting breakthrough research and the unwavering respect and support of the breast cancer community. Schneider will remain a visible presence at Komen events, thought leadership forums, and community initiatives.

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Contacts

Media contact:
press@komen.org

Susan G. Komen


Release Versions

Contacts

Media contact:
press@komen.org

More News From Susan G. Komen

Susan G. Komen® Flags Upcoming Changes Coming to Health Care Coverage; Leads Advocacy Efforts to Protect Breast Cancer Community

WASHINGTON--(BUSINESS WIRE)--The Susan G. Komen® Center for Public Policy announced its 2026 state and federal advocacy priorities, underscoring the urgent need to protect the breast cancer community from impending changes that will drastically change affordability and access to health care. At both the federal and state levels, policymakers are weighing proposals that could significantly increase costs, reduce coverage and weaken critical cancer programs. From the uncertain future of access to...

Federal Government Reopens: Susan G. Komen® Emphasizes More Work Remains to Ensure Access to Health Insurance

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen, the world’s leading breast cancer organization acknowledges the legislation signed into law late yesterday reopening the federal government and ending the record long 43-day shutdown. The law funds most federal agencies at current levels through January 30, 2026, and includes full-year fiscal 2026 funding for the Department of Agriculture, Food and Drug Administration, the Department of Veterans Affairs, as well as military construction projects and...

Susan G. Komen® Honors Grand Ole Opry’s Dan Rogers with the 2025 Promise Award

NASHVILLE, Tenn.--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, awarded Executive Producer and Senior Vice President of The Grand Ole Opry, Dan Rogers with the 2025 Promise Award, recognizing his commitment to Komen’s mission to end breast cancer. He was presented with the award at the annual Opry Goes Pink Fundraiser on October 25, 2025, in Nashville, Tennessee. As Senior Vice President of The Grand Ole Opry, Dan has supported Komen for over 17 years, hostin...
Back to Newsroom